Examining the association of smoking with work productivity and associated costs in Japan

被引:25
|
作者
Suwa, Kiyomi [1 ]
Flores, Natalia M. [2 ]
Yoshikawa, Reiko [1 ]
Goto, Rei [3 ]
Vietri, Jeffrey [4 ]
Igarashi, Ataru [5 ]
机构
[1] Pfizer Japan Inc, Shibuya Ku, Tokyo, Japan
[2] Kantar Hlth, Hlth Outcomes Practice, Foster City, CA USA
[3] Keio Univ, Keio Business Sch, Grad Sch Business Adm, Yokohama, Kanagawa, Japan
[4] Kantar Hlth, Hlth Outcomes Practice, Horsham, PA USA
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Drug Policy & Management, Tokyo, Japan
关键词
Smoking cessation; Work productivity; Activity impairment; Indirect costs; SCALE MANUFACTURING ENTERPRISES; CESSATION; LIFE; SYMPTOMS; GERMANY; SAVINGS; SMOKERS;
D O I
10.1080/13696998.2017.1352507
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Smoking is associated with significant health and economic burden globally, including an increased risk of many leading causes of mortality and significant impairments in work productivity. This burden is attenuated by successful tobacco cessation, including reduced risk of disease and improved productivity. The current study aimed to show the benefits of smoking cessation for work-place productivity and decreased costs associated with loss of work impairment. Materials and methods: The data source was the 2011 Japan National Health and Wellness Survey (n=30,000). Respondents aged 20-64 were used in the analyses (n=23,738) and were categorized into: current smokers, former smokers, and never smokers. Generalized linear models controlling for demographics and health characteristics examined the relationship of smoking status with the Work Productivity and Activity Impairment questionnaire (WPAI-GH) endpoints, as well as estimated indirect costs. Results: Current smokers reported the greatest overall work impairment, including absenteeism (i.e. work time missed) and presenteeism (i.e. impairment while at work); however, after controlling for covariates, there were no significant differences between former smokers and never smokers on overall work impairment. Current smokers and former smokers had greater activity impairment (i.e. impairment in daily activities) than never smokers. Current smokers reported the highest indirect costs (i.e. costs associated with work impairment); however, after controlling for covariates, there were no significant differences between former smokers and never smokers on indirect costs. Limitations and conclusions: Smoking exerts a large health and economic burden; however, smoking cessation attenuates this burden. The current study provides important further evidence of this association, with former smokers appearing statistically indistinguishable from never smokers in terms of work productivity loss and associated indirect costs among a large representative sample of Japanese workers. This report highlights the workplace benefits of smoking cessation across productivity markers and cost-savings.
引用
收藏
页码:938 / 944
页数:7
相关论文
共 50 条
  • [1] BENEFITS OF QUITTING SMOKING IN JAPAN ON WORKING PRODUCTIVITY AND ACTIVITY IMPAIRMENT AND INDIRECT COSTS
    Suwa, K.
    Yoshikawa, R.
    Igarashi, A.
    Goto, R.
    Vietri, J.
    Flores, N. M.
    VALUE IN HEALTH, 2016, 19 (07) : A559 - A559
  • [2] Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer
    Kypriotakis, George
    Kim, Seokhun
    Karam-Hage, Maher
    Robinson, Jason D.
    Minnix, Jennifer A.
    Blalock, Janice A.
    Cui, Yong
    Beneventi, Diane
    Kim, Bumyang
    Pan, I. -Wen
    Shih, Ya-Chen Tina
    Cinciripini, Paul M.
    CANCER PREVENTION RESEARCH, 2024, 17 (05) : 217 - 225
  • [3] Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea
    Dasari, Arvind
    Joish, Vijay N.
    Perez-Olle, Raul
    Dharba, Sam
    Balaji, Kavitha
    Halperin, Daniel M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (05) : 507 - 511
  • [4] Healthcare costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus
    Panopalis, Pantelis
    Yazdany, Jinoos
    Gillis, Joann Zell.
    Julian, Laura
    Trupin, Laura
    Hersh, Aimee
    Criswell, Lindsey
    Katz, Patti
    Yelin, Ed
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S925 - S926
  • [5] Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031
    Sharif, B.
    Garner, R.
    Hennessy, D.
    Sanmartin, C.
    Flanagan, W. M.
    Marshall, D. A.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (02) : 249 - 258
  • [6] Difficulties in calculating productivity costs: Work disability associated with Borderline Personality Disorder
    van Asselt, Antoinette D. I.
    Dirksen, Carmen D.
    Arntz, Arnoud
    Severens, Johan L.
    VALUE IN HEALTH, 2008, 11 (04) : 637 - 644
  • [7] Health Care Costs and Costs Associated With Changes in Work Productivity Among Persons With Systemic Lupus Erythematosus
    Panopalis, Pantelis
    Yazdany, Jinoos
    Gillis, Joann Zell
    Julian, Laura
    Trupin, Laura
    Hersh, Aimee O.
    Criswell, Lindsey A.
    Katz, Patricia
    Yelin, Edward
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12): : 1788 - 1795
  • [8] Workplace smoking related absenteeism and productivity costs in Taiwan
    Tsai, SP
    Wen, CP
    Hu, SC
    Cheng, TY
    Huang, SJ
    TOBACCO CONTROL, 2005, 14 : I33 - I37
  • [9] Costs of Smoking-Attributable Productivity Losses in Poland
    Lasocka, Joanna
    Jakubczyk, Michal
    Siekmeier, Ruediger
    RESPIRATORY REGULATION - CLINICAL ADVANCES, 2013, 755 : 179 - 187
  • [10] Association between work productivity and sleep health: A cross-sectional study in Japan
    Ishibashi, Yoshiki
    Shimura, Akiyoshi
    SLEEP HEALTH, 2020, 6 (03) : 270 - 276